Warfarin
Warfarin is a pharmaceutical drug with 303 clinical trials. Currently 22 active trials ongoing. Historical success rate of 93.4%.
Success Metrics
Based on 212 completed trials
Phase Distribution
Phase Distribution
85
Early Stage
35
Mid Stage
109
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
89.8%
212 of 236 finished
10.2%
24 ended early
22
trials recruiting
303
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Clinical Trial to Evaluate MK-4208/TERN-701 in Healthy Adult Participants (MK-4208-001/TERN701-1014)
An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis
Low INR to Minimize Bleeding With Mechanical Valves Trial
Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE
SWITCH: Apixaban vs Vitamin K in HM3
Clinical Trials (303)
A Clinical Trial to Evaluate MK-4208/TERN-701 in Healthy Adult Participants (MK-4208-001/TERN701-1014)
An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis
Low INR to Minimize Bleeding With Mechanical Valves Trial
Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE
SWITCH: Apixaban vs Vitamin K in HM3
Aspirin Monotherapy Versus Sequential Warfarin-Aspirin Therapy After TAVR in Patients With Pure Aortic Regurgitation
Apixaban Versus Warfarin for Left Ventricular Thrombus
Replication of the EINSTEIN-DVT Anticoagulant Trial in Healthcare Claims Data
Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki Disease
Assessment of TRanscathetEr and Surgical Aortic BiOprosthetic Valve Thrombosis and Its TrEatment With Anticoagulation
RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrome
Rivaroxaban vs. Warfarin for Post Cardiac Surgery Atrial Fibrillation
The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis
A Study on How CagriSema Affects Levels of Atorvastatin and Warfarin in the Blood of Participants With Excess Body Weight
Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients With Non-Valvular Atrial Fibrillation
An Observational Study to Learn More About How Safe Treatment With Rivaroxaban is in Children in Japan With Venous Thromboembolism
An Open-label, DDI Study to Investigate the Effects of Amlitelimab on the PK of Selected Cytochrome P450 Substrates
Determinants of Warfarin Metabolism
Interaction of BI 425809 With Midazolam, Warfarin, Omeprazole and Digoxin
Efficacy and Safety of Oral Rivaroxaban in Cerebrosinovenous Thrombosis
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 303